Follow the people · Insider
C. Frank Bennett
C. Frank Bennett files insider transactions with the SEC as an evp, chief scientific officer of Ionis Pharmaceuticals (IONS). We hold 5 disclosed purchases and sales filed since 4 January 2006, 1 of them in the last 90 days.
- Files forIONS
- Disclosed buys and sells5 in all, 1 in the last 90 days
- Last disclosure2 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 January 2016 — 31 August 2026EVP, Chief Scientific Officer · Ionis Pharmaceuticals (IONS)221 Form 4 lines · source: SEC Form 4
- Filed 1 January 2006 — 16 December 2015SVP, Antisense Research · Isis Pharmaceuticals (ISIS)215 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 20,000 shares of Ionis PharmaceuticalsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- exercised options over 48,626 shares of Ionis PharmaceuticalsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 48,626 shares of Ionis PharmaceuticalsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- exercised options over 16,463 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 February 2026Non-Qualified Stock Option (right to buy) · traded 2 February 2026 · filed 4 February 2026
- exercised options over 48,626 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 February 2026Non-Qualified Stock Option (right to buy) · traded 2 February 2026 · filed 4 February 2026
- exercised options over 16,463 shares of Ionis PharmaceuticalsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 16,463 shares of Ionis PharmaceuticalsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- was granted 11,421 shares of Ionis PharmaceuticalsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 5,885 shares of Ionis PharmaceuticalsSEC Form 42 February 2026Common Stock · traded 30 January 2026 · filed 2 February 2026
- was granted 11,421 shares of Ionis PharmaceuticalsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 5,885 shares of Ionis PharmaceuticalsSEC Form 42 February 2026Common Stock · traded 30 January 2026 · filed 2 February 2026
- exercised options over 21,055 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 15 January 2026 · filed 20 January 2026
- ▼ sold on the open market 8,977 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 16 January 2026 · filed 20 January 2026
- was granted 25,800 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Performance Restricted Stock Units · traded 15 January 2026 · filed 20 January 2026
- was granted 25,800 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Performance Restricted Stock Units · traded 15 January 2026 · filed 20 January 2026
- exercised options over 21,055 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- was granted 9,675 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- exercised options over 21,055 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- was granted 9,675 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- exercised options over 21,055 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 15 January 2026 · filed 20 January 2026
- ▼ sold on the open market 8,977 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 16 January 2026 · filed 20 January 2026
- was granted 19,350 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 46 January 2026Non-Qualified Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 19,350 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 46 January 2026Non-Qualified Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 6,000 shares of Ionis PharmaceuticalsSEC Form 49 September 2025Common Stock · traded 5 September 2025 · filed 9 September 2025
- exercised options over 46,800 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 September 2025Non-Qualified Stock Option (right to buy) · traded 3 September 2025 · filed 4 September 2025
- ▼ sold on the open market 5,000 shares of Ionis PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- exercised options over 46,800 shares of Ionis PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- ▼ sold on the open market 33,909 shares of Ionis PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- exercised options over 12,891 shares of Ionis PharmaceuticalsSEC Form 44 September 2025Common Stock · traded 3 September 2025 · filed 4 September 2025
- acquired or disposed of, other 213 shares of Ionis PharmaceuticalsSEC Form 43 September 2025Common Stock · traded 29 August 2025 · filed 3 September 2025
- exercised options over 10,000 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 August 2025Non-Qualified Stock Option (right to buy) · traded 18 August 2025 · filed 20 August 2025
- exercised options over 10,000 shares of Ionis PharmaceuticalsSEC Form 420 August 2025Common Stock · traded 18 August 2025 · filed 20 August 2025
- ▼ sold on the open market 10,000 shares of Ionis PharmaceuticalsSEC Form 420 August 2025Common Stock · traded 18 August 2025 · filed 20 August 2025
- acquired or disposed of, other 320 shares of Ionis PharmaceuticalsSEC Form 44 March 2025Common Stock · traded 28 February 2025 · filed 4 March 2025
- was granted 3,607 shares of Ionis PharmaceuticalsSEC Form 43 February 2025Common Stock · traded 30 January 2025 · filed 3 February 2025
- ▼ sold on the open market 1,327 shares of Ionis PharmaceuticalsSEC Form 43 February 2025Common Stock · traded 31 January 2025 · filed 3 February 2025
- was granted 22,000 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2025Performance Restricted Stock Units · traded 15 January 2025 · filed 17 January 2025
- was granted 33,000 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2025Restricted Stock Unit · traded 15 January 2025 · filed 17 January 2025
- exercised options over 18,011 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2025Restricted Stock Unit · traded 15 January 2025 · filed 17 January 2025
- exercised options over 18,011 shares of Ionis PharmaceuticalsSEC Form 417 January 2025Common Stock · traded 15 January 2025 · filed 17 January 2025
- ▼ sold on the open market 6,752 shares of Ionis PharmaceuticalsSEC Form 417 January 2025Common Stock · traded 16 January 2025 · filed 17 January 2025
- was granted 22,000 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 46 January 2025Non-Qualified Stock Option (right to buy) · traded 2 January 2025 · filed 6 January 2025
- ▼ sold on the open market 1,885 shares of Ionis PharmaceuticalsSEC Form 44 September 2024Common Stock · traded 2 February 2024 · filed 4 September 2024
- acquired or disposed of, other 177 shares of Ionis PharmaceuticalsSEC Form 44 September 2024Common Stock · traded 30 August 2024 · filed 4 September 2024
- acquired or disposed of, other 383 shares of Ionis PharmaceuticalsSEC Form 44 March 2024Common Stock · traded 29 February 2024 · filed 4 March 2024
- was granted 3,609 shares of Ionis PharmaceuticalsSEC Form 42 February 2024Common Stock · traded 1 February 2024 · filed 2 February 2024
- ▼ sold on the open market 1,853 shares of Ionis PharmaceuticalsSEC Form 42 February 2024Common Stock · traded 2 February 2024 · filed 2 February 2024
- exercised options over 18,314 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 418 January 2024Restricted Stock Unit · traded 16 January 2024 · filed 18 January 2024
- exercised options over 18,314 shares of Ionis PharmaceuticalsSEC Form 418 January 2024Common Stock · traded 16 January 2024 · filed 18 January 2024
- ▼ sold on the open market 6,745 shares of Ionis PharmaceuticalsSEC Form 418 January 2024Common Stock · traded 17 January 2024 · filed 18 January 2024
- was granted 17,000 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2024Performance Restricted Stock Units · traded 15 January 2024 · filed 17 January 2024
- was granted 20,400 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2024Restricted Stock Unit · traded 15 January 2024 · filed 17 January 2024
- was granted 27,200 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 January 2024Non-Qualified Stock Option (right to buy) · traded 2 January 2024 · filed 4 January 2024
- exercised options over 6,500 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 422 December 2023Non-Qualified Stock Option (right to buy) · traded 20 December 2023 · filed 22 December 2023
- exercised options over 16,113 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 422 December 2023Non-Qualified Stock Option (right to buy) · traded 21 December 2023 · filed 22 December 2023
- exercised options over 6,500 shares of Ionis PharmaceuticalsSEC Form 422 December 2023Common Stock · traded 20 December 2023 · filed 22 December 2023
- ▼ sold on the open market 6,500 shares of Ionis PharmaceuticalsSEC Form 422 December 2023Common Stock · traded 20 December 2023 · filed 22 December 2023
- exercised options over 16,113 shares of Ionis PharmaceuticalsSEC Form 422 December 2023Common Stock · traded 21 December 2023 · filed 22 December 2023
- ▼ sold on the open market 16,113 shares of Ionis PharmaceuticalsSEC Form 422 December 2023Common Stock · traded 21 December 2023 · filed 22 December 2023
- exercised options over 14,002 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 418 December 2023Non-Qualified Stock Option (right to buy) · traded 14 December 2023 · filed 18 December 2023
- exercised options over 8,610 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 418 December 2023Non-Qualified Stock Option (right to buy) · traded 14 December 2023 · filed 18 December 2023
- exercised options over 14,002 shares of Ionis PharmaceuticalsSEC Form 418 December 2023Common Stock · traded 14 December 2023 · filed 18 December 2023
- ▼ sold on the open market 14,002 shares of Ionis PharmaceuticalsSEC Form 418 December 2023Common Stock · traded 14 December 2023 · filed 18 December 2023
- exercised options over 8,610 shares of Ionis PharmaceuticalsSEC Form 418 December 2023Common Stock · traded 14 December 2023 · filed 18 December 2023
- ▼ sold on the open market 8,610 shares of Ionis PharmaceuticalsSEC Form 418 December 2023Common Stock · traded 14 December 2023 · filed 18 December 2023
- ▼ sold on the open market 4,460 shares of Ionis PharmaceuticalsSEC Form 429 September 2023Common Stock · traded 28 September 2023 · filed 29 September 2023
- acquired or disposed of, other 180 shares of Ionis PharmaceuticalsSEC Form 45 September 2023Common Stock · traded 31 August 2023 · filed 5 September 2023
- acquired or disposed of, other 383 shares of Ionis PharmaceuticalsSEC Form 42 March 2023Common Stock · traded 28 February 2023 · filed 2 March 2023
- was granted 3,609 shares of Ionis PharmaceuticalsSEC Form 47 February 2023Common Stock · traded 3 February 2023 · filed 7 February 2023
- ▼ sold on the open market 1,813 shares of Ionis PharmaceuticalsSEC Form 47 February 2023Common Stock · traded 6 February 2023 · filed 7 February 2023
- exercised options over 19,417 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 419 January 2023Restricted Stock Unit · traded 17 January 2023 · filed 19 January 2023
- exercised options over 19,417 shares of Ionis PharmaceuticalsSEC Form 419 January 2023Common Stock · traded 17 January 2023 · filed 19 January 2023
- ▼ sold on the open market 6,978 shares of Ionis PharmaceuticalsSEC Form 419 January 2023Common Stock · traded 18 January 2023 · filed 19 January 2023
- was granted 13,656 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 418 January 2023Performance Restricted Stock Units · traded 15 January 2023 · filed 18 January 2023
- was granted 16,387 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 418 January 2023Restricted Stock Unit · traded 15 January 2023 · filed 18 January 2023
- was granted 21,849 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 45 January 2023Non-Qualified Stock Option (right to buy) · traded 3 January 2023 · filed 5 January 2023
- acquired or disposed of, other 183 shares of Ionis PharmaceuticalsSEC Form 41 September 2022Common Stock · traded 31 August 2022 · filed 1 September 2022
- acquired or disposed of, other 346 shares of Ionis PharmaceuticalsSEC Form 42 March 2022Common Stock · traded 28 February 2022 · filed 2 March 2022
- exercised options over 18,842 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2022Restricted Stock Unit · traded 18 January 2022 · filed 20 January 2022
- exercised options over 18,842 shares of Ionis PharmaceuticalsSEC Form 420 January 2022Common Stock · traded 18 January 2022 · filed 20 January 2022
- had shares withheld for tax on 6,726 shares of Ionis PharmaceuticalsSEC Form 420 January 2022Common Stock · traded 18 January 2022 · filed 20 January 2022
- was granted 10,826 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 419 January 2022Performance Restricted Stock Units · traded 15 January 2022 · filed 19 January 2022
- was granted 14,435 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 419 January 2022Restricted Stock Unit · traded 15 January 2022 · filed 19 January 2022
- was granted 28,869 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 45 January 2022Non-Qualified Stock Option (right to buy) · traded 3 January 2022 · filed 5 January 2022
- acquired or disposed of, other 151 shares of Ionis PharmaceuticalsSEC Form 42 September 2021Common Stock · traded 31 August 2021 · filed 2 September 2021
- acquired or disposed of, other 112 shares of Ionis PharmaceuticalsSEC Form 42 March 2021Common Stock · traded 26 February 2021 · filed 2 March 2021
- was granted 20,822 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2021Restricted Stock Units · traded 15 January 2021 · filed 20 January 2021
- exercised options over 15,520 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2021Restricted Stock Units · traded 15 January 2021 · filed 20 January 2021
- exercised options over 15,520 shares of Ionis PharmaceuticalsSEC Form 420 January 2021Common Stock · traded 15 January 2021 · filed 20 January 2021
- had shares withheld for tax on 5,488 shares of Ionis PharmaceuticalsSEC Form 420 January 2021Common Stock · traded 15 January 2021 · filed 20 January 2021
- was granted 46,850 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 46 January 2021Employee Stock Option (right to buy) · traded 4 January 2021 · filed 6 January 2021
- exercised options over 7,947 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 48 December 2020Employee Stock Option (right to buy) · traded 4 December 2020 · filed 8 December 2020
- exercised options over 7,947 shares of Ionis PharmaceuticalsSEC Form 48 December 2020Common Stock · traded 4 December 2020 · filed 8 December 2020
- ▼ sold on the open market 7,947 shares of Ionis PharmaceuticalsSEC Form 48 December 2020Common Stock · traded 4 December 2020 · filed 8 December 2020
- exercised options over 7,053 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 44 December 2020Employee Stock Option (right to buy) · traded 2 December 2020 · filed 4 December 2020
- exercised options over 7,053 shares of Ionis PharmaceuticalsSEC Form 44 December 2020Common Stock · traded 2 December 2020 · filed 4 December 2020
- ▼ sold on the open market 7,053 shares of Ionis PharmaceuticalsSEC Form 44 December 2020Common Stock · traded 2 December 2020 · filed 4 December 2020
- exercised options over 15,000 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 45 November 2020Employee Stock Option (right to buy) · traded 3 November 2020 · filed 5 November 2020
- exercised options over 15,000 shares of Ionis PharmaceuticalsSEC Form 45 November 2020Common Stock · traded 3 November 2020 · filed 5 November 2020
- ▼ sold on the open market 15,000 shares of Ionis PharmaceuticalsSEC Form 45 November 2020Common Stock · traded 3 November 2020 · filed 5 November 2020
- acquired or disposed of, other 112 shares of Ionis PharmaceuticalsSEC Form 42 September 2020Common Stock · traded 31 August 2020 · filed 2 September 2020
- exercised options over 15,000 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 429 June 2020Employee Stock Option (right to buy) · traded 25 June 2020 · filed 29 June 2020
- exercised options over 15,000 shares of Ionis PharmaceuticalsSEC Form 429 June 2020Common Stock · traded 25 June 2020 · filed 29 June 2020
- ▼ sold on the open market 15,000 shares of Ionis PharmaceuticalsSEC Form 429 June 2020Common Stock · traded 25 June 2020 · filed 29 June 2020
- acquired or disposed of, other 169 shares of Ionis PharmaceuticalsSEC Form 43 March 2020Common Stock · traded 29 February 2020 · filed 3 March 2020
- was granted 21,612 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2020Restricted Stock Units · traded 15 January 2020 · filed 17 January 2020
- exercised options over 11,711 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2020Restricted Stock Units · traded 15 January 2020 · filed 17 January 2020
- exercised options over 11,711 shares of Ionis PharmaceuticalsSEC Form 417 January 2020Common Stock · traded 15 January 2020 · filed 17 January 2020
- had shares withheld for tax on 4,162 shares of Ionis PharmaceuticalsSEC Form 417 January 2020Common Stock · traded 15 January 2020 · filed 17 January 2020
- was granted 48,626 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 43 January 2020Employee Stock Option (right to buy) · traded 2 January 2020 · filed 3 January 2020
- acquired or disposed of, other 118 shares of Ionis PharmaceuticalsSEC Form 42 July 2019Common Stock · traded 1 July 2019 · filed 2 July 2019
- exercised options over 9,013 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 45 February 2019Employee Stock Option (right to buy) · traded 1 February 2019 · filed 5 February 2019
- exercised options over 9,013 shares of Ionis PharmaceuticalsSEC Form 45 February 2019Common Stock · traded 1 February 2019 · filed 5 February 2019
- ▼ sold on the open market 9,013 shares of Ionis PharmaceuticalsSEC Form 45 February 2019Common Stock · traded 1 February 2019 · filed 5 February 2019
- was granted 20,797 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2019Restricted Stock Units · traded 15 January 2019 · filed 17 January 2019
- exercised options over 7,822 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 417 January 2019Restricted Stock Units · traded 15 January 2019 · filed 17 January 2019
- exercised options over 7,822 shares of Ionis PharmaceuticalsSEC Form 417 January 2019Common Stock · traded 15 January 2019 · filed 17 January 2019
- had shares withheld for tax on 2,818 shares of Ionis PharmaceuticalsSEC Form 417 January 2019Common Stock · traded 15 January 2019 · filed 17 January 2019
- was granted 46,800 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 43 January 2019Employee Stock Option (right to buy) · traded 2 January 2019 · filed 3 January 2019
- acquired or disposed of, other 128 shares of Ionis PharmaceuticalsSEC Form 43 January 2019Common Stock · traded 1 January 2019 · filed 3 January 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.